Trial · NCT05102591
Results by group89
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 89
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Assessment of Recruitment Rate | Parallel-group Design | 1.1 | Standard Deviation 1.5 | participants per month | |
| Assessment of Recruitment Rate | Crossover Design | 0.6 | Standard Deviation 1.0 | participants per month | |
| Reduction in Pain Severity | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | 1 hour post-intervention | 2.9 | Standard Deviation 2.9 | units on a scale |
| Reduction in Pain Severity | REN (Initial Treatment; Parallel and Crossover Phases) | 1 hour post-intervention | 2.1 | Standard Deviation 1.3 | units on a scale |
| Reduction in Pain Severity | Standard-of-Care IV (Crossover Treatment; Crossover Phase) | 1 hour post-intervention | 3 | Standard Deviation 0 | units on a scale |
| Reduction in Pain Severity | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | 2 hours post-intervention | 4 | Standard Deviation 3.5 | units on a scale |
| Reduction in Pain Severity | REN (Initial Treatment; Parallel and Crossover Phases) | 2 hours post-intervention | 2.4 | Standard Deviation 1.6 | units on a scale |
| Reduction in Pain Severity | Standard-of-Care IV (Crossover Treatment; Crossover Phase) | 2 hours post-intervention | 3.5 | Standard Deviation 0.7 | units on a scale |
| Reduction in Pain Severity | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | 48 hours post-intervention | 3.3 | Standard Deviation 2.7 | units on a scale |
| Reduction in Pain Severity | REN (Initial Treatment; Parallel and Crossover Phases) | 48 hours post-intervention | 2.6 | Standard Deviation 1.5 | units on a scale |
| Number of Eligible Participants Who Are Screened, Enrolled, and Complete All Assessments | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | 10 | Participants | ||
| Number of Eligible Participants Who Are Screened, Enrolled, and Complete All Assessments | REN (Initial Treatment; Parallel and Crossover Phases) | 9 | Participants | ||
| Number of Eligible Participants Who Are Screened, Enrolled, and Complete All Assessments | Standard-of-Care IV (Crossover Treatment; Crossover Phase) | 2 | Participants | ||
| Global Impression of Change | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | 2 Hours | 5 | participants | |
| Global Impression of Change | REN (Initial Treatment; Parallel and Crossover Phases) | 2 Hours | 3 | participants | |
| Global Impression of Change | Standard-of-Care IV (Crossover Treatment; Crossover Phase) | 2 Hours | 1 | participants | |
| Global Impression of Change | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | 48 Hours | 5 | participants | |
| Global Impression of Change | REN (Initial Treatment; Parallel and Crossover Phases) | 48 Hours | 3 | participants | |
| Global Impression of Change | Standard-of-Care IV (Crossover Treatment; Crossover Phase) | 48 Hours | 1 | participants | |
| Study Feedback From Participants and Staff | Standard-of-Care IV (Initial Treatment; Parallel and Crossover Phases) | I would be interested in using device instead of IV to treat future migraine attacks in the ED. | 3.9 | Standard Deviation 1 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05102591/results